AFACART Clinical Trial: Preliminary Results For Persistent A-Fib
My new 2015 AF Symposium report is of special interest for patients with persistent Atrial Fibrillation.
Dr. Sebastian Knecht from CHU Brugmann, Brussels, Belgium presented preliminary findings from the AFACART clinical trial testing the effectiveness of ‘Panoramic Electrographic Non-Invasive Mapping’, specifically the CardioInsight—ECVUE System, as compared to conventional mapping and ablation procedures.
In the clinical trial, patients with persistent A-Fib receive an ablation using the ECVUE mapping/ablation system, then there is a 12-month follow-up period.
In an important change to standard ablation procedures, Dr. Knecht described the first step in the ECGI/ECVUE ablation process as ablation of A-Fib drivers (rotors and foci). This is in contrast to the ‘step-wise’ approach that begins with ablation of the openings of the pulmonary veins.
To read more, see my 2015 AF Symposium article, AFACART Clinical Trial: Preliminary Results of the CardioInsight—ECVUE System in Multiple Centers.